Genentech, the biotechnology company, posted a 41 percent increase in second-quarter profit on sales of its cancer drugs, continuing a positive earnings streak.
More: continued here
| Home | Photos | Surgery Types | Cosmetic Surgeons | Surgery Prices | Surgery Risks | Plastic Surgery News |
Sales of Cancer Drugs Give Genentech Profit a Lift (New York Times)
Related News
Leave a Reply
News by Category
- Arm Lift (592)
- Botox (491)
- Breast Augmentation (270)
- Breast Lift (366)
- Brow Lift (113)
- Butt Lift (263)
- Celebrity Plastic Surgery (152)
- Chin Augmentation (9)
- Collagen (510)
- Ear Surgery (492)
- Eyelid Lift (38)
- Face Lift (212)
- Forehead Lift (128)
- Hair Replacement (490)
- Laser Skin Resurfacing (83)
- LASIK (1456)
- Lip Augmentation (20)
- Liposuction (502)
- Nose Job (976)
- Plastic Surgery (89)
- Thigh Lift (210)
- Tummy Tuck (1323)
- Weight Loss Surgery (2471)